RHYTHM PHARMACEUTICALS, INC.
RYTM
43 insider filings · Latest: Sep 14, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Aug 11, 2025 | Aug 11 8:22 PM | JOSEPH SHULMAN | Proposed Sale | 3,984 | $91.98 | $366.4K | — | View → |
| Jul 9, 2025 | Jul 9 8:17 PM | CHRISTOPHER PAUL GERMAN | Proposed Sale | 3,817 | $65.14 | $248.6K | — | View → |
| Jul 9, 2025 | Jul 9 8:17 PM | PAMELA CRAMER | Proposed Sale | 15,572 | $65.14 | $1.0M | — | View → |
| Jul 9, 2025 | Jul 9 8:16 PM | HUNTER SMITH | Proposed Sale | 42,120 | $65.14 | $2.7M | — | View → |
| Jul 9, 2025 | Jul 9 8:16 PM | JOSEPH J SHULMAN | Proposed Sale | 7,969 | $65.14 | $519.1K | — | View → |
| Jun 10, 2025 | Jun 10 8:21 PM | CHRISTOPHER PAUL GERMAN | Proposed Sale | 2,069 | $66.72 | $138.0K | — | View → |
| Jun 6, 2025 | Jun 6 8:25 PM | PAMELA CRAMER | Proposed Sale | 7,031 | $66.18 | $465.3K | — | View → |
| Jun 3, 2025 | Jun 3 8:27 PM | DAVID W MCGIRR | Proposed Sale | 65,431 | $63.66 | $4.2M | — | View → |
| Jun 3, 2025 | Jun 3 8:27 PM | DAVID MEEKER | Proposed Sale | 43,621 | $63.66 | $2.8M | — | View → |
| May 30, 2025 | May 30 8:35 PM | HUNTER SMITH | Proposed Sale | 23,400 | $61.88 | $1.4M | — | View → |
| Apr 29, 2025 | Apr 29 8:21 PM | YANN MAZZABRAUD | Proposed Sale | 6,745 | $64.41 | $434.4K | — | View → |
| Apr 29, 2025 | Apr 29 8:20 PM | PAMELA CRAMER | Proposed Sale | 7,031 | $64.41 | $452.9K | — | View → |
| Apr 8, 2025 | Apr 8 8:18 PM | PAMELA CRAMER | Proposed Sale | 20,760 | $54.96 | $1.1M | — | View → |
| Apr 8, 2025 | Apr 8 8:16 PM | YANN MAZZABRAUD | Proposed Sale | 17,750 | $54.96 | $975.5K | — | View → |
| Mar 14, 2025 | Mar 14 8:21 PM | YANN MAZZABRAUD | Proposed Sale | 75,000 | $50.24 | $3.8M | — | View → |
| Feb 13, 2025 | Feb 13 9:31 PM | JENNIFER KAYDEN LEE | Proposed Sale | 1,205 | $57.64 | $69.5K | — | View → |
| Feb 12, 2025 | Feb 12 9:42 PM | JENNIFER KAYDEN LEE | Proposed Sale | 1,205 | $57.58 | $69.4K | — | View → |
| Feb 10, 2025 | Feb 10 9:34 PM | JENNIFER KAYDEN LEE | Proposed Sale | 4,189 | $59.18 | $247.9K | — | View → |
| Feb 5, 2025 | Feb 5 9:20 PM | JENNIFER KAYDEN LEE | Proposed Sale | 3,066 | $59.95 | $183.8K | — | View → |
| Nov 7, 2024 | Nov 7 9:36 PM | PAMELA CRAMER | Proposed Sale | 4,688 | $62.65 | $293.7K | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Apr 1, 2026 | Apr 3 9:36 PM | Yann MazabraudEVP, Head of International | Option Exercise | 12,875 | — | 5,000(D) | View → |
| Apr 1, 2026 | Apr 3 9:35 PM | Kimberly J PopovitsDirector | Grant/Award | 17,065 | $88.12 | 10,257(D) | View → |
| Mar 4, 2026 | Mar 6 9:51 PM | Christopher Paul GermanCorporate Controller & CAO | Option Exercise | 1,500 | $17.97 | 3,731(D) | View → |
| Mar 2, 2026 | Mar 5 1:22 AM | Yann MazabraudEVP, Head of International | Grant/Award | 35,000 | $94.94 | 35,000(D) | View → |
| Mar 1, 2026 | Mar 4 12:45 AM | Christopher Paul GermanCorporate Controller & CAO | Option Exercise | 1,162 | — | 1,162(D) | View → |
| Mar 2, 2026 | Mar 3 1:56 AM | Hunter C SmithChief Financial Officer | Option Exercise | 6,099 | $6.80 | 91,401(D) | View → |
| Feb 14, 2026 | Feb 18 9:30 PM | Yann MazabraudEVP, Head of International | Option Exercise | 10,000 | — | 30,000(D) | View → |
| Feb 11, 2026 | Feb 13 10:53 PM | Joseph ShulmanChief Technical Officer | Grant/Award | 37,500 | $98.47 | 22,500(D) | View → |
| Feb 11, 2026 | Feb 13 10:52 PM | David P MeekerDirector, President and CEO | Grant/Award | 179,750 | $98.47 | 107,850(D) | View → |
| Feb 11, 2026 | Feb 13 10:50 PM | Yann MazabraudEVP, Head of International | Grant/Award | 23,350 | — | 23,350(D) | View → |
| Feb 11, 2026 | Feb 13 10:49 PM | Jennifer Kayden LeeEVP, Head of North America | Grant/Award | 54,150 | $98.47 | 32,500(D) | View → |
| Feb 11, 2026 | Feb 13 10:48 PM | Christopher Paul GermanCorporate Controller & CAO | Grant/Award | 5,215 | — | 5,215(D) | View → |
| Feb 11, 2026 | Feb 13 10:47 PM | Alastair GarfieldChief Scientific Officer | Grant/Award | 41,650 | $98.47 | 25,000(D) | View → |
| Feb 11, 2026 | Feb 13 10:45 PM | Pamela J. CramerChief Human Resources Officer | Grant/Award | 29,150 | $98.47 | 17,500(D) | View → |
| Feb 11, 2026 | Feb 13 1:56 AM | Hunter C SmithChief Financial Officer | Grant/Award | 62,500 | $98.47 | 37,500(D) | View → |
| Feb 1, 2026 | Feb 3 9:38 PM | Yann MazabraudEVP, Head of International | Option Exercise | 5,500 | — | 11,000(D) | View → |
| Feb 1, 2026 | Feb 3 9:36 PM | Hunter C SmithChief Financial Officer | Option Exercise | 26,000 | — | 31,237(D) | View → |
| Feb 1, 2026 | Feb 3 9:35 PM | Joseph ShulmanChief Technical Officer | Option Exercise | 16,968 | — | 18,750(D) | View → |
| Feb 1, 2026 | Feb 3 9:34 PM | David P MeekerDirector, President and CEO | Option Exercise | 68,713 | — | 100,012(D) | View → |
| Feb 1, 2026 | Feb 3 9:33 PM | Jennifer Kayden LeeEVP, Head of North America | Option Exercise | 22,612 | — | 27,487(D) | View → |